The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Azacitidine Drug Market Research Report 2025
Synopsis
Azacitidine is used to treat myelodysplastic syndromes (MDS), a number of disorders in which not enough healthy blood cells are produced in the bone marrow, leaving patients with low blood counts. In healthy bone marrow, stem cells become red blood cells, white blood cells or platelets. In MDS, this process is dysfunctional.
The global Azacitidine Drug market was valued at US$ 91 million in 2023 and is anticipated to reach US$ 112.4 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Azacitidine Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azacitidine Drug.
Report Scope
The Azacitidine Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Azacitidine Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azacitidine Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Mylan
Shilpa Medicare
Accord Healthcare
Natco Pharma
Dr. Reddy's Laboratories
MBA Pharmaceuticals Pvt Ltd
Taj Generics
Getwell Oncology
EVER Pharma
Xpreza
Shubham Pharmaceutical
Rizochem Pharmaceutical
Segment by Type
Vidaza®
Generic Vidaza®
Segment by Application
Refractory anemia (RA)
Refractory anemia with excess blasts (RAEB)
Chronic myelomonocytic leukemia (CMMoL)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Azacitidine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Azacitidine is used to treat myelodysplastic syndromes (MDS), a number of disorders in which not enough healthy blood cells are produced in the bone marrow, leaving patients with low blood counts. In healthy bone marrow, stem cells become red blood cells, white blood cells or platelets. In MDS, this process is dysfunctional.
The global Azacitidine Drug market was valued at US$ 91 million in 2023 and is anticipated to reach US$ 112.4 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Azacitidine Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azacitidine Drug.
Report Scope
The Azacitidine Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Azacitidine Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azacitidine Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Mylan
Shilpa Medicare
Accord Healthcare
Natco Pharma
Dr. Reddy's Laboratories
MBA Pharmaceuticals Pvt Ltd
Taj Generics
Getwell Oncology
EVER Pharma
Xpreza
Shubham Pharmaceutical
Rizochem Pharmaceutical
Segment by Type
Vidaza®
Generic Vidaza®
Segment by Application
Refractory anemia (RA)
Refractory anemia with excess blasts (RAEB)
Chronic myelomonocytic leukemia (CMMoL)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Azacitidine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Azacitidine Drug Market Overview
1.1 Product Overview and Scope of Azacitidine Drug
1.2 Azacitidine Drug Segment by Type
1.2.1 Global Azacitidine Drug Market Value Comparison by Type (2024-2030)
1.2.2 Vidaza®
1.2.3 Generic Vidaza®
1.3 Azacitidine Drug Segment by Application
1.3.1 Global Azacitidine Drug Market Value by Application: (2024-2030)
1.3.2 Refractory anemia (RA)
1.3.3 Refractory anemia with excess blasts (RAEB)
1.3.4 Chronic myelomonocytic leukemia (CMMoL)
1.3.5 Others
1.4 Global Azacitidine Drug Market Size Estimates and Forecasts
1.4.1 Global Azacitidine Drug Revenue 2019-2030
1.4.2 Global Azacitidine Drug Sales 2019-2030
1.4.3 Global Azacitidine Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Azacitidine Drug Market Competition by Manufacturers
2.1 Global Azacitidine Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Azacitidine Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Azacitidine Drug Average Price by Manufacturers (2019-2024)
2.4 Global Azacitidine Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Azacitidine Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azacitidine Drug, Product Type & Application
2.7 Azacitidine Drug Market Competitive Situation and Trends
2.7.1 Azacitidine Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Azacitidine Drug Players Market Share by Revenue
2.7.3 Global Azacitidine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Azacitidine Drug Retrospective Market Scenario by Region
3.1 Global Azacitidine Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Azacitidine Drug Global Azacitidine Drug Sales by Region: 2019-2030
3.2.1 Global Azacitidine Drug Sales by Region: 2019-2024
3.2.2 Global Azacitidine Drug Sales by Region: 2025-2030
3.3 Global Azacitidine Drug Global Azacitidine Drug Revenue by Region: 2019-2030
3.3.1 Global Azacitidine Drug Revenue by Region: 2019-2024
3.3.2 Global Azacitidine Drug Revenue by Region: 2025-2030
3.4 North America Azacitidine Drug Market Facts & Figures by Country
3.4.1 North America Azacitidine Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Azacitidine Drug Sales by Country (2019-2030)
3.4.3 North America Azacitidine Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Azacitidine Drug Market Facts & Figures by Country
3.5.1 Europe Azacitidine Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Azacitidine Drug Sales by Country (2019-2030)
3.5.3 Europe Azacitidine Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azacitidine Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Azacitidine Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Azacitidine Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Azacitidine Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Azacitidine Drug Market Facts & Figures by Country
3.7.1 Latin America Azacitidine Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Azacitidine Drug Sales by Country (2019-2030)
3.7.3 Latin America Azacitidine Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azacitidine Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Azacitidine Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Azacitidine Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Azacitidine Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Azacitidine Drug Sales by Type (2019-2030)
4.1.1 Global Azacitidine Drug Sales by Type (2019-2024)
4.1.2 Global Azacitidine Drug Sales by Type (2025-2030)
4.1.3 Global Azacitidine Drug Sales Market Share by Type (2019-2030)
4.2 Global Azacitidine Drug Revenue by Type (2019-2030)
4.2.1 Global Azacitidine Drug Revenue by Type (2019-2024)
4.2.2 Global Azacitidine Drug Revenue by Type (2025-2030)
4.2.3 Global Azacitidine Drug Revenue Market Share by Type (2019-2030)
4.3 Global Azacitidine Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Azacitidine Drug Sales by Application (2019-2030)
5.1.1 Global Azacitidine Drug Sales by Application (2019-2024)
5.1.2 Global Azacitidine Drug Sales by Application (2025-2030)
5.1.3 Global Azacitidine Drug Sales Market Share by Application (2019-2030)
5.2 Global Azacitidine Drug Revenue by Application (2019-2030)
5.2.1 Global Azacitidine Drug Revenue by Application (2019-2024)
5.2.2 Global Azacitidine Drug Revenue by Application (2025-2030)
5.2.3 Global Azacitidine Drug Revenue Market Share by Application (2019-2030)
5.3 Global Azacitidine Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Celgene Azacitidine Drug Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Azacitidine Drug Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Shilpa Medicare
6.3.1 Shilpa Medicare Corporation Information
6.3.2 Shilpa Medicare Description and Business Overview
6.3.3 Shilpa Medicare Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shilpa Medicare Azacitidine Drug Product Portfolio
6.3.5 Shilpa Medicare Recent Developments/Updates
6.4 Accord Healthcare
6.4.1 Accord Healthcare Corporation Information
6.4.2 Accord Healthcare Description and Business Overview
6.4.3 Accord Healthcare Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Accord Healthcare Azacitidine Drug Product Portfolio
6.4.5 Accord Healthcare Recent Developments/Updates
6.5 Natco Pharma
6.5.1 Natco Pharma Corporation Information
6.5.2 Natco Pharma Description and Business Overview
6.5.3 Natco Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Natco Pharma Azacitidine Drug Product Portfolio
6.5.5 Natco Pharma Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 MBA Pharmaceuticals Pvt Ltd
6.6.1 MBA Pharmaceuticals Pvt Ltd Corporation Information
6.6.2 MBA Pharmaceuticals Pvt Ltd Description and Business Overview
6.6.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio
6.7.5 MBA Pharmaceuticals Pvt Ltd Recent Developments/Updates
6.8 Taj Generics
6.8.1 Taj Generics Corporation Information
6.8.2 Taj Generics Description and Business Overview
6.8.3 Taj Generics Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taj Generics Azacitidine Drug Product Portfolio
6.8.5 Taj Generics Recent Developments/Updates
6.9 Getwell Oncology
6.9.1 Getwell Oncology Corporation Information
6.9.2 Getwell Oncology Description and Business Overview
6.9.3 Getwell Oncology Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Getwell Oncology Azacitidine Drug Product Portfolio
6.9.5 Getwell Oncology Recent Developments/Updates
6.10 EVER Pharma
6.10.1 EVER Pharma Corporation Information
6.10.2 EVER Pharma Description and Business Overview
6.10.3 EVER Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 EVER Pharma Azacitidine Drug Product Portfolio
6.10.5 EVER Pharma Recent Developments/Updates
6.11 Xpreza
6.11.1 Xpreza Corporation Information
6.11.2 Xpreza Azacitidine Drug Description and Business Overview
6.11.3 Xpreza Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Xpreza Azacitidine Drug Product Portfolio
6.11.5 Xpreza Recent Developments/Updates
6.12 Shubham Pharmaceutical
6.12.1 Shubham Pharmaceutical Corporation Information
6.12.2 Shubham Pharmaceutical Azacitidine Drug Description and Business Overview
6.12.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shubham Pharmaceutical Azacitidine Drug Product Portfolio
6.12.5 Shubham Pharmaceutical Recent Developments/Updates
6.13 Rizochem Pharmaceutical
6.13.1 Rizochem Pharmaceutical Corporation Information
6.13.2 Rizochem Pharmaceutical Azacitidine Drug Description and Business Overview
6.13.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Rizochem Pharmaceutical Azacitidine Drug Product Portfolio
6.13.5 Rizochem Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azacitidine Drug Industry Chain Analysis
7.2 Azacitidine Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azacitidine Drug Production Mode & Process
7.4 Azacitidine Drug Sales and Marketing
7.4.1 Azacitidine Drug Sales Channels
7.4.2 Azacitidine Drug Distributors
7.5 Azacitidine Drug Customers
8 Azacitidine Drug Market Dynamics
8.1 Azacitidine Drug Industry Trends
8.2 Azacitidine Drug Market Drivers
8.3 Azacitidine Drug Market Challenges
8.4 Azacitidine Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Azacitidine Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Azacitidine Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Azacitidine Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Azacitidine Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Azacitidine Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Azacitidine Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Azacitidine Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Azacitidine Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Azacitidine Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Azacitidine Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Azacitidine Drug, Product Type & Application
Table 12. Global Key Manufacturers of Azacitidine Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Azacitidine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azacitidine Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Azacitidine Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Azacitidine Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Azacitidine Drug Sales Market Share by Region (2019-2024)
Table 19. Global Azacitidine Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Azacitidine Drug Sales Market Share by Region (2025-2030)
Table 21. Global Azacitidine Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Azacitidine Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Azacitidine Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Azacitidine Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Azacitidine Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Azacitidine Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Azacitidine Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Azacitidine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Azacitidine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Azacitidine Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Azacitidine Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Azacitidine Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Azacitidine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Azacitidine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Azacitidine Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Azacitidine Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Azacitidine Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Azacitidine Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Azacitidine Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Azacitidine Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Azacitidine Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Azacitidine Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Azacitidine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Azacitidine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Azacitidine Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Azacitidine Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Azacitidine Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Azacitidine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Azacitidine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Azacitidine Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Azacitidine Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Azacitidine Drug Sales Market Share by Type (2019-2024)
Table 53. Global Azacitidine Drug Sales Market Share by Type (2025-2030)
Table 54. Global Azacitidine Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Azacitidine Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Azacitidine Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Azacitidine Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Azacitidine Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Azacitidine Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Azacitidine Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Azacitidine Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Azacitidine Drug Sales Market Share by Application (2019-2024)
Table 63. Global Azacitidine Drug Sales Market Share by Application (2025-2030)
Table 64. Global Azacitidine Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Azacitidine Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Azacitidine Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Azacitidine Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Azacitidine Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Azacitidine Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Celgene Corporation Information
Table 71. Celgene Description and Business Overview
Table 72. Celgene Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Celgene Azacitidine Drug Product
Table 74. Celgene Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Azacitidine Drug Product
Table 79. Mylan Recent Developments/Updates
Table 80. Shilpa Medicare Corporation Information
Table 81. Shilpa Medicare Description and Business Overview
Table 82. Shilpa Medicare Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Shilpa Medicare Azacitidine Drug Product
Table 84. Shilpa Medicare Recent Developments/Updates
Table 85. Accord Healthcare Corporation Information
Table 86. Accord Healthcare Description and Business Overview
Table 87. Accord Healthcare Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Accord Healthcare Azacitidine Drug Product
Table 89. Accord Healthcare Recent Developments/Updates
Table 90. Natco Pharma Corporation Information
Table 91. Natco Pharma Description and Business Overview
Table 92. Natco Pharma Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Natco Pharma Azacitidine Drug Product
Table 94. Natco Pharma Recent Developments/Updates
Table 95. Dr. Reddy's Laboratories Corporation Information
Table 96. Dr. Reddy's Laboratories Description and Business Overview
Table 97. Dr. Reddy's Laboratories Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Dr. Reddy's Laboratories Azacitidine Drug Product
Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
Table 100. MBA Pharmaceuticals Pvt Ltd Corporation Information
Table 101. MBA Pharmaceuticals Pvt Ltd Description and Business Overview
Table 102. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product
Table 104. MBA Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 105. Taj Generics Corporation Information
Table 106. Taj Generics Description and Business Overview
Table 107. Taj Generics Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Taj Generics Azacitidine Drug Product
Table 109. Taj Generics Recent Developments/Updates
Table 110. Getwell Oncology Corporation Information
Table 111. Getwell Oncology Description and Business Overview
Table 112. Getwell Oncology Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Getwell Oncology Azacitidine Drug Product
Table 114. Getwell Oncology Recent Developments/Updates
Table 115. EVER Pharma Corporation Information
Table 116. EVER Pharma Description and Business Overview
Table 117. EVER Pharma Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. EVER Pharma Azacitidine Drug Product
Table 119. EVER Pharma Recent Developments/Updates
Table 120. Xpreza Corporation Information
Table 121. Xpreza Description and Business Overview
Table 122. Xpreza Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Xpreza Azacitidine Drug Product
Table 124. Xpreza Recent Developments/Updates
Table 125. Shubham Pharmaceutical Corporation Information
Table 126. Shubham Pharmaceutical Description and Business Overview
Table 127. Shubham Pharmaceutical Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Shubham Pharmaceutical Azacitidine Drug Product
Table 129. Shubham Pharmaceutical Recent Developments/Updates
Table 130. Rizochem Pharmaceutical Corporation Information
Table 131. Rizochem Pharmaceutical Description and Business Overview
Table 132. Rizochem Pharmaceutical Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Rizochem Pharmaceutical Azacitidine Drug Product
Table 134. Rizochem Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Azacitidine Drug Distributors List
Table 138. Azacitidine Drug Customers List
Table 139. Azacitidine Drug Market Trends
Table 140. Azacitidine Drug Market Drivers
Table 141. Azacitidine Drug Market Challenges
Table 142. Azacitidine Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Azacitidine Drug
Figure 2. Global Azacitidine Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Azacitidine Drug Market Share by Type in 2023 & 2030
Figure 4. Vidaza® Product Picture
Figure 5. Generic Vidaza® Product Picture
Figure 6. Global Azacitidine Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Azacitidine Drug Market Share by Application in 2023 & 2030
Figure 8. Refractory anemia (RA)
Figure 9. Refractory anemia with excess blasts (RAEB)
Figure 10. Chronic myelomonocytic leukemia (CMMoL)
Figure 11. Others
Figure 12. Global Azacitidine Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Azacitidine Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Azacitidine Drug Sales (2019-2030) & (K Units)
Figure 15. Global Azacitidine Drug Average Price (USD/Unit) & (2019-2030)
Figure 16. Azacitidine Drug Report Years Considered
Figure 17. Azacitidine Drug Sales Share by Manufacturers in 2023
Figure 18. Global Azacitidine Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Azacitidine Drug Players: Market Share by Revenue in 2023
Figure 20. Azacitidine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Azacitidine Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Azacitidine Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Azacitidine Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Azacitidine Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Azacitidine Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Azacitidine Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Azacitidine Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Azacitidine Drug Sales Market Share by Country (2019-2030)
Figure 46. Latin America Azacitidine Drug Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Azacitidine Drug Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Azacitidine Drug Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Azacitidine Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Azacitidine Drug by Type (2019-2030)
Figure 56. Global Revenue Market Share of Azacitidine Drug by Type (2019-2030)
Figure 57. Global Azacitidine Drug Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Azacitidine Drug by Application (2019-2030)
Figure 59. Global Revenue Market Share of Azacitidine Drug by Application (2019-2030)
Figure 60. Global Azacitidine Drug Price (USD/Unit) by Application (2019-2030)
Figure 61. Azacitidine Drug Value Chain
Figure 62. Azacitidine Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
